Our study has confirmed that the ACT is an ideal tool for routine use in asthma control evaluation in Chinese primary health-care facilities. In the study, the ACT demonstrated good reliability and ...

Using a percent recovery index (PRI) to predict poor asthma control and exacerbations in adults may be an effective tool in navigating treatment options and management of the disease, a study finds.

Please provide your email address to receive an email when new articles are posted on . Bifidobacterium infantis 35624 can decrease levels of dysfunctional T regulatory cells. There were no ...

Please provide your email address to receive an email when new articles are posted on . The Asthma Impairment and Risk Questionnaire (AIRQ) measures current control and future exacerbation risk. 35% ...

The digital asthma self-management program significantly improved symptom control, especially for those with uncontrolled asthma, showing a 2.8-point Asthma Control Test score difference over usual ...

Cladosporium is a genus of ubiquitous environmental fungi that has been reported to induce asthma and colonize the airways of both healthy and asthmatic individuals. A study presented at the CHEST ...

In adults with asthma, a digital asthma self-management (DASM) program improved symptom control compared with usual care, although its effectiveness varied by race, with weaker results observed among ...

In a recent study published in the Respiratory Research journal, researchers in Hong Kong assessed the deterioration of asthma control in patients recovering from mild to moderate coronavirus disease ...

Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.